Table of Contents Author Guidelines Submit a Manuscript
Journal of Tropical Medicine
Volume 2016, Article ID 7073894, 8 pages
http://dx.doi.org/10.1155/2016/7073894
Research Article

Atherogenic Risk Assessment among Persons Living in Rural Uganda

1Medical Research Council/Uganda Virus Research Institute Uganda Research Unit on AIDS, Entebbe, Uganda
2Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA
3Johns Hopkins School of Medicine, Baltimore, MD 21205, USA

Received 28 April 2016; Revised 27 May 2016; Accepted 29 May 2016

Academic Editor: Marcel Tanner

Copyright © 2016 Clara Wekesa et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. World Health Organisation, Cardiovascular Diseases (CVDs), World Health Organisation, Geneva, Switzerland, 2013.
  2. A. D. Alwan, G. Galea, and D. Stuckler, “Development at risk: addressing noncommunicable diseases at the United Nations high-level meeting,” Bulletin of the World Health Organization, vol. 89, no. 8, pp. 546–546A, 2011. View at Publisher · View at Google Scholar · View at Scopus
  3. J. J. Dalal, T. N. Padmanabhan, P. Jain, S. Patil, H. Vasnawala, and A. Gulati, “Lipitension: Interplay between dyslipidemia and hypertension,” Indian Journal of Endocrinology and Metabolism, vol. 16, no. 2, pp. 240–245, 2012. View at Publisher · View at Google Scholar
  4. M. Twagirumukiza, D. de Bacquer, J. G. Kips, G. de Backer, R. V. Stichele, and L. M. Van Bortel, “Current and projected prevalence of arterial hypertension in sub-Saharan Africa by sex, age and habitat: an estimate from population studies,” Journal of Hypertension, vol. 29, no. 7, pp. 1243–1252, 2011. View at Publisher · View at Google Scholar · View at Scopus
  5. P. Kotwani, D. Kwarisiima, T. D. Clark et al., “Epidemiology and awareness of hypertension in a rural Ugandan community: a cross-sectional study,” BMC Public Health, vol. 13, article 1151, 2013. View at Publisher · View at Google Scholar · View at Scopus
  6. G. Musinguzi and F. Nuwaha, “Prevalence, awareness and control of hypertension in Uganda,” PLoS ONE, vol. 8, no. 4, Article ID e62236, 2013. View at Publisher · View at Google Scholar · View at Scopus
  7. W. B. Kannel, “Fifty years of Framingham study contributions to understanding hypertension,” Journal of Human Hypertension, vol. 14, no. 2, pp. 83–90, 2000. View at Publisher · View at Google Scholar · View at Scopus
  8. A. Bottger, H. A. Van Lith, V. Kren et al., “Quantitative trait loci influencing cholesterol and phospholipid phenotypes map to chromosomes that contain genes regulating blood pressure in the spontaneously hypertensive rat,” Journal of Clinical Investigation, vol. 98, no. 3, pp. 856–862, 1996. View at Publisher · View at Google Scholar · View at Scopus
  9. F. Thomas, K. Bean, L. Guize, S. Quentzel, P. Argyriadis, and A. Benetos, “Combined effects of systolic blood pressure and serum cholesterol on cardiovascular mortality in young (< years) men and women,” European Heart Journal, vol. 23, no. 7, pp. 528–535, 2002. View at Publisher · View at Google Scholar · View at Scopus
  10. P. Castelli and K. Anderson, “A population at risk: prevalence of high cholesterol levels in hypertensive patients in the Framingham study,” The American Journal of Medicine, vol. 80, no. 2, pp. 33–39, 1986. View at Google Scholar
  11. P. W. F. Wilson, R. B. D'Agostino, D. Levy, A. M. Belanger, H. Silbershatz, and W. B. Kannel, “Prediction of coronary heart disease using risk factor categories,” Circulation, vol. 97, pp. 1837–1847, 1998. View at Publisher · View at Google Scholar
  12. M. R. Law, N. J. Wald, and S. G. Thompson, “By how much and how quickly does reduction in serum cholesterol concentration lower risk of ischaemic heart disease?” British Medical Journal, vol. 308, no. 6925, pp. 367–372, 1994. View at Publisher · View at Google Scholar · View at Scopus
  13. J. Millán, X. Pintó, A. Muñoz et al., “Lipoprotein ratios: physiological significance and clinical usefulness in cardiovascular prevention,” Vascular Health and Risk Management, vol. 5, pp. 757–765, 2009. View at Google Scholar · View at Scopus
  14. H. R. Superko and S. King, “Lipid management to reduce cardiovascular risk: a new strategy is required,” Circulation, vol. 117, pp. 560–568, 2008. View at Google Scholar
  15. M. Dobiášová, “Atherogenic index of plasma [log(triglycerides/HDL-cholesterol)]: theoretical and practical implications,” Clinical Chemistry, vol. 50, no. 7, pp. 1113–1115, 2004. View at Publisher · View at Google Scholar · View at Scopus
  16. V. Bittner, B. D. Johnson, I. Zineh et al., “The triglyceride/high-density lipoprotein cholesterol ratio predicts all-cause mortality in women with suspected myocardial ischemia. A Report From the Women's Ischemia Syndrome Evaluation (WISE),” American Heart Journal, vol. 157, no. 3, pp. 548–555, 2009. View at Publisher · View at Google Scholar · View at Scopus
  17. J. M. Gaziano, C. H. Hennekens, C. J. O'Donnell, J. L. Breslow, and J. E. Buring, “Fasting triglycerides, high-density lipoprotein, and risk of myocardial infarction,” Circulation, vol. 96, no. 8, pp. 2520–2525, 1997. View at Publisher · View at Google Scholar · View at Scopus
  18. U. Nwagha, E. J. Ikekpeazu, F. E. Ejezie, E. E. Neboh, and I. C. Maduka, “Atherogenic index of plasma as useful predictor of cardiovascular risk among postmenopausal women in Enugu, Nigeria,” African Health Sciences, vol. 10, no. 3, pp. 248–252, 2010. View at Google Scholar · View at Scopus
  19. K. Wan, J. Zhao, H. Huang et al., “The association between triglyceride/high-density lipoprotein cholesterol ratio and all-cause mortality in acute coronary syndrome after coronary revascularization,” PLoS ONE, vol. 10, no. 4, Article ID e0123521, 2015. View at Publisher · View at Google Scholar · View at Scopus
  20. W. P. Castelli, “Epidemiology of coronary heart disease: The Framingham Study,” The American Journal of Medicine, vol. 76, no. 2, pp. 4–12, 1984. View at Publisher · View at Google Scholar · View at Scopus
  21. M. Dobiášová, “AIP—atherogenic index of plasma as a significant predictor of cardiovascular risk: from research to practice,” Vnitrni Lekarstvi, vol. 52, no. 1, pp. 64–71, 2006. View at Google Scholar · View at Scopus
  22. D. Guwatudde, G. Mutungi, R. Wesonga et al., “The epidemiology of hypertension in Uganda: findings from the national non-communicable diseases risk factor survey,” PLoS ONE, vol. 10, no. 9, Article ID e0138991, 2015. View at Publisher · View at Google Scholar · View at Scopus
  23. G. Asiki, G. A. V. Murphy, K. Baisley et al., “Prevalence of dyslipidaemia and associated risk factors in a rural population in South-Western Uganda: a community based survey,” PLoS ONE, vol. 10, no. 5, Article ID e0126166, 2015. View at Publisher · View at Google Scholar · View at Scopus
  24. G. F. Watts, “Treating patients with low HDL-cholesterol: choices, issues and opportunities,” Current Controlled Trials in Cardiovascular Medicine, vol. 2, no. 3, pp. 118–122, 2001. View at Publisher · View at Google Scholar · View at Scopus
  25. G. Asiki, G. Murphy, J. Nakiyingi-Miiro et al., “The general population cohort in rural south-western Uganda: a platform for communicable and non-communicable disease studies,” International Journal of Epidemiology, vol. 42, no. 1, pp. 129–141, 2013. View at Publisher · View at Google Scholar
  26. J. Riha, A. Karabarinde, G. Ssenyomo et al., “Urbanicity and lifestyle risk factors for cardiometabolic diseases in rural Uganda: a cross-sectional study,” PLoS Medicine, vol. 11, no. 7, Article ID e1001683, 2014. View at Publisher · View at Google Scholar · View at Scopus
  27. WHO, Use of Glycated Haemoglobin (HbA1c) in the Diagnosis of Diabetes Mellitus, World Health Organization, 2011.
  28. Uganda National Policy Guidelines for HIV Counselling and Testing Ministry of Health Uganda, 2003.
  29. National Guidelines for Research Involving Humans as Research Participants, UNCST, Kampala, Uganda, 2007.
  30. J. Idemudia, E. Ugwuja, O. Afonja, E. Idogun, and N. Ugwu, “C-Reactive proteins and cardiovascular risk indices in hypertensive Nigerians,” The Internet Journal of Cardiovascular Research, vol. 6, no. 2, 2008. View at Google Scholar
  31. S. Niroumand, M. Khajedaluee, M. Khadem-Rezaiyan et al., “Atherogenic Index of Plasma (AIP): a marker of cardiovascular disease,” Medical Journal of The Islamic Republic of Iran (MJIRI), vol. 29, p. 240, 2015. View at Google Scholar
  32. S. Yusuf, S. Hawken, S. Ôunpuu et al., “Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study,” The Lancet, vol. 364, no. 9438, pp. 937–952, 2004. View at Publisher · View at Google Scholar · View at Scopus
  33. P. L. Da Luz, D. Favarato, J. R. Faria-Neto Jr., P. Lemos, and A. C. P. Chagas, “High ratio of triglycerides to HDL-cholesterol predicts extensive coronary disease,” Clinics, vol. 63, no. 4, pp. 427–432, 2008. View at Publisher · View at Google Scholar · View at Scopus
  34. D. Périard, A. Telenti, P. Sudre et al., “Atherogenic dyslipidemia in HIV-infected individuals treated with protease inhibitors,” Circulation, vol. 100, no. 7, pp. 700–705, 1999. View at Publisher · View at Google Scholar · View at Scopus
  35. V. A. Triant, “HIV infection and coronary heart disease: an intersection of epidemics,” Journal of Infectious Diseases, vol. 205, no. 3, pp. S355–S361, 2012. View at Publisher · View at Google Scholar · View at Scopus
  36. C. J. O'Donnell and R. Elosua, “Cardiovascular risk factors. Insights from framingham heart study,” Revista Española de Cardiología, vol. 61, no. 3, pp. 299–310, 2008. View at Publisher · View at Google Scholar